RNK Health NAD+ Overview 2026: $129/Mo Compounded NAD+ - Subscription Terms, Refund Restrictions, and 7 Things to Verify Before You Subscribe

DES MOINES, Iowa, March 28, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only and does not constitute medical advice. It discusses a telehealth program involving compounded prescription medication that requires evaluation by a licensed clinician. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. This article contains affiliate links, and a commission may be earned at no additional cost to you if a purchase is made.

RNK Health NAD+ Review 2026: Is This Injectable Longevity Therapy Worth It?

RNK Health offers compounded prescription NAD+ starting from $129 per month through a telehealth model with three delivery formats - but the subscription terms, refund restrictions, and clinical oversight structure deserve a careful look before you enter your payment information. This article breaks down what the company's own published materials actually say.

If you are researching RNK Health's NAD+ program, you are probably trying to answer a few specific questions: Is this platform legitimate? What exactly am I paying for each month? What happens if the medication does not work for me? And what does the fine print say about cancellation, billing, and refunds? Those are the right questions, and this article was built to answer them using the company's own terms of service, refund policy, telehealth consent documentation, and current clinical literature on NAD+ as a molecule.

Here is the honest starting point: published research has fueled scientific interest in NAD+ as a molecule involved in cellular energy metabolism and other biological processes associated with aging. But that interest does not establish clinical outcomes for any specific compounded product. The gap between what NAD+ does at the molecular level and what any finished compounded formulation delivers in your body is real, and this article will be straightforward about where that line sits.

According to RNK Health's website, the platform offers compounded prescription NAD+ in injectable, nasal, and liposomal formats, with pricing starting from $129 per month, subject to clinician approval and current site terms. Consumers are encouraged to evaluate telehealth platforms carefully and review clinician guidance, product sourcing, and regulatory disclosures before beginning any prescription-based program.

View current RNK Health NAD+ program details (via partner page)

This article is based on publicly available RNK Health materials, telehealth consent documentation, and current clinical literature to provide a balanced, research-informed overview.

RNK Health NAD+ at a Glance: Key Details From the Company's Own Materials

What it is: A telehealth platform offering compounded prescription NAD+ - not a supplement - requiring clinician approval before dispensing.

Delivery formats listed: Injectable (subcutaneous), nasal, and liposomal liquid.

Starting price: From $129 per month, according to the company's website.

Platform entity: RNK Health LLC (does not practice medicine, per its terms of service).

Medical providers: OpenLoop Healthcare Partners, PC and affiliated entities (independent licensed clinicians; may include nurse practitioners or physician assistants).

Partner pharmacy: Located in Springville, UT; compounds and dispenses medication.

FDA status: Compounded medications are not reviewed or approved by the FDA as finished products.

Refund policy for NAD+: No refunds once medication has shipped, including for dosage dissatisfaction. The GLP-1 money-back guarantee does not apply to NAD+.

Cancellation: Cancel anytime, but requests must be received at least two days before your billing date.

Billing note: Access fees continue to be billed while you complete required steps such as monthly refill forms.

What You Are Actually Evaluating: A Compounded Prescription, Not a Supplement

This is the single most important thing to understand before going any further. When you sign up for RNK Health's NAD+ program, you are not buying a supplement off a shelf. You are entering a process where an independent licensed medical provider reviews your health information and decides - entirely at their discretion - whether to write you a prescription for a compounded medication prepared by a licensed pharmacy.

Compounded medications are not reviewed or approved by the FDA as finished products. According to RNK Health's own telehealth consent form, the FDA does not approve nor review compounded products for safety, effectiveness, or quality. The consent form also states that compounding pharmacies are licensed pharmacies subject to state and federal regulations and must adhere to strict quality control standards - but that is not the same thing as FDA product approval, and you should understand the difference clearly before moving forward.

The active molecule - NAD+ - has been studied extensively at the research level. But the specific compounded formulation you would receive through RNK Health has not undergone independent FDA review as a finished product. This distinction matters because it affects what you can reasonably expect and what protections exist if something does not work the way you hoped.

The Three Entities Behind Your RNK Health NAD+ Experience

Telehealth platforms like RNK Health operate through a structure that separates who does what. Understanding this matters because it determines who is actually responsible at each step of your care - and who is not.

RNK Health LLC is the platform. It handles the technology and administrative side - the website, subscription management, and customer coordination. According to the company's terms of service, RNK Health's role is limited to making information available and facilitating access to services on behalf of the Professional Entities. The terms state explicitly that the company does not engage in the practice of medicine or provide any other health services. RNK Health is not your doctor. It is not the entity deciding whether you receive a prescription.

OpenLoop Healthcare Partners, PC and its affiliated entities - including state-specific professional corporations in California, Colorado, New Jersey, Wisconsin, Puerto Rico, and Reliant MD Medical Associates PLLC - serve as the Professional Entities. These are the independent licensed medical providers who review your health information and determine whether a prescription is appropriate for you. According to the terms of service, RNK Health is independent from these Professional Entities and is not responsible for their acts, omissions, or communications.

A detail worth knowing: RNK Health's homepage uses the phrase "1-on-1 calls with US doctors," while its telehealth consent form also states that in some cases the provider may be a nurse practitioner or physician assistant rather than a physician. Both are licensed clinicians, but if the distinction between physician and non-physician provider matters to you, it is worth asking about before your consultation.

The partner pharmacy - located at 863 W 450 S, Ste 101, Springville, UT 84663 - is the licensed facility that compounds and dispenses your medication once a prescription is written. The pharmacy operates independently from both the platform and the clinical providers.

This three-entity structure is standard across telehealth platforms. No single entity handles everything, and the clinical decision about whether you receive a prescription rests entirely with the evaluating clinician - not with RNK Health as a company.

NAD+ at the Molecular Level: What Published Research Actually Shows

The research discussed in this section relates to NAD+ biology and published ingredient-level literature, not to independent clinical trials of RNK Health's finished compounded formulations. That distinction needs to stay front of mind the entire way through.

NAD+ - nicotinamide adenine dinucleotide - is a coenzyme found in every living cell. It participates in hundreds of metabolic reactions, functioning as an essential cofactor in redox reactions that contribute to cellular energy production (ATP) and as a co-substrate for enzymes involved in DNA repair, gene expression, and cellular communication.

A 2025 expert review published in Nature Aging, bringing together more than 25 scientists from institutions including the University of Oslo, highlighted that NAD+ levels naturally decrease as people age. This decline has been observed in human skin, liver, and brain tissue - though not uniformly across all tissue types, and the pattern in humans still requires further investigation. The review noted that in animal models, restoring NAD+ levels has shown effects on metabolism, stress resilience, and lifespan, but emphasized the need for more human data before drawing definitive conclusions.

Researchers have identified three primary drivers of age-related NAD+ loss: persistent PARP activation in response to accumulated DNA damage, CD38-mediated NADase activity during chronic low-grade inflammation (sometimes called "inflammaging"), and a decline in the NAMPT salvage pathway the body uses to recycle NAD+. These mechanisms have been documented across multiple peer-reviewed publications and represent an area of active scientific investigation.

A separate 2025 review in Clinical Bioenergetics confirmed that NAD+ is essential for metabolism, energy production, gene regulation, and cellular communication, and that age-related NAD+ decline may be partly responsible for functional changes associated with aging.

A March 2026 summary published through ScienceDaily, covering the Nature Aging review, described NAD+ as a molecule that plays a central role in producing energy, repairing DNA, and keeping cells functioning - while noting that the combined scientific insights highlight a growing global effort to understand how this molecule may support healthier aging.

Where the evidence gets more complicated:

Most human clinical data on NAD+ supplementation comes from oral studies using precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) - not from injectable, nasal, or liposomal NAD+ delivery specifically. While the biological rationale for direct NAD+ delivery exists - potentially bypassing some digestive absorption losses - the specific clinical outcomes of injectable versus oral NAD+ therapy have not been definitively compared in large-scale, rigorous human trials. Some supplementation studies have shown benefits while others have shown no observable advantages, which suggests that individual factors including age, baseline health, and genetics play significant roles in determining response.

No regulatory body currently recognizes NAD+ therapy as a standard treatment for aging or disease, and ongoing research is still evaluating its role in human health.

This is ingredient-level and molecule-level research. These findings do not establish that RNK Health's compounded NAD+ products produce specific clinical outcomes. Individual responses to NAD+ therapy vary, and published research has produced mixed results across study populations.

The Three Delivery Formats RNK Health Lists

According to the company's website, RNK Health lists NAD+ in three delivery formats. Each represents a different administration route. The evaluating clinician - not you and not the platform - determines which format and which dosage is appropriate based on your individual health information.

NAD+ Injectable (Subcutaneous): This is a subcutaneous delivery format listed by the brand. It involves self-administered injections under the skin at home. According to the company's NAD+-specific refund policy, dosages are customized by the licensed clinician based on clinical assessment, treatment typically starts at a lower dose and is titrated upward for safety, and some patients may be prescribed up to 2400 mg depending on their existing NAD+ usage history. The company lists pricing starting from $129 per month.

NAD+ Nasal: This is a non-injection option listed by the brand. According to the company's website, nasal NAD+ is described using energy-and-mood marketing language, with pricing starting from $129 per month. Nasal delivery administers NAD+ through the nasal mucosa, and the specific formulation and dosing are determined by the evaluating clinician.

NAD+ Liposomal Liquid: This is an oral-format option listed by the brand. The company describes it using positioning language related to longevity-focused consumer interest, with pricing starting from $129 per month. Liposomal delivery uses lipid-based encapsulation, and this option may appeal to consumers who prefer to avoid injections or nasal administration.

All pricing is based on the company's website as of the date of this publication and is subject to change. Verify current pricing, available delivery formats, and subscription terms directly on the official RNK Health website before making any decisions.

Review current RNK Health NAD+ pricing and terms (via partner page)

How the RNK Health NAD+ Process Works, Step by Step

According to the company's website, the program follows four steps:

Step 1: Choose your medication. You select the NAD+ delivery format that interests you - injectable, nasal, or liposomal liquid.

Step 2: Complete the free quiz. You fill out a health questionnaire that provides the clinical team with the information they need to evaluate your eligibility. This is where you share your health history, current medications, and relevant background.

Step 3: Receive medication upon approval. If the evaluating clinician determines that NAD+ therapy is appropriate for your situation, a prescription is written and fulfilled through the partner pharmacy. According to the company, the platform markets delivery within approximately 48 hours of approval. However, completing a questionnaire is not a guarantee that you will receive a prescription. The telehealth consent states that the provider may determine a telehealth visit is not appropriate for you, in which case your request will not be submitted and you will need to seek care through another channel.

Step 4: Work with the clinical team. According to the company, the program includes ongoing access to clinicians and support. RNK Health markets this as access to one-on-one calls with U.S. doctors, while its telehealth consent also states that in some cases the provider may be a nurse practitioner or physician assistant.

According to the company's subscription FAQ, the subscription price may encompass consultations and form reviews with a provider, medications fulfilled through the pharmacy, care support, a 24/7 patient support line, and blood panels if required by the clinician. The specific services, labs, and medications covered may vary.

Pricing, Subscription Structure, and What the Fine Print Actually Says

This is the section you should read most carefully, because the subscription mechanics matter just as much as the monthly price itself.

Starting price: According to the company's website, NAD+ programs start from $129 per month.

What the subscription covers: Per the company's FAQ, the price may include access to clinical consultations, medication, care support, and the 24/7 patient support line - though the specific services, labs, and medications included may vary.

Billing structure: According to the terms of service, access fees provide immediate access to the clinical team and are billed based on the selected term - monthly, quarterly, or annually. Here is the detail that matters: your access remains active and access fees continue to be billed while you complete required steps such as monthly refill forms. In plain language, the billing does not pause if you have not yet submitted your refill form.

Monthly refill requirement: To receive your next medication shipment, the company states you must complete a monthly refill form. Your subscription continues and billing continues regardless of whether you have completed this step.

Dosage decisions: All dosages are determined by the prescribing clinician based on clinical assessment. If you want to start at a higher dose - the refund policy specifically references 2400 mg for NAD+ - you must provide information about your current NAD+ usage history, including your current dose, how long you have been taking it, how frequently you use it, and the date of your last dose.

Cancellation and Refund Terms for NAD+: Read This Before You Sign Up

Pay close attention here. The refund terms for NAD+ are materially different from the refund terms for RNK Health's GLP-1 weight loss program, and the difference is significant enough that you should understand it fully before entering your payment information.

Cancellation: According to the company's published refund policy, you may cancel at any time and for any reason. However, your cancellation request must be received at least two days before your billing date. If that notice window is missed, your subscription will be charged on the next billing date and the cancellation takes effect the following cycle. After cancellation, you continue to have access through the end of your current billing cycle.

NAD+ refund eligibility: According to the company's NAD+-specific refund policy, once medication has been shipped and delivered, refunds are not available - regardless of the reason, including dissatisfaction with your dosage. The policy states that dosage decisions are made based on medical necessity and patient safety, and refunds will not be provided if the dosage you receive differs from what you expected or wanted.

The GLP-1 money-back guarantee does not apply to NAD+. This is worth emphasizing. The company's refund policy includes a "100% Money-Back Guarantee" specifically and exclusively for GLP-1 medications (Semaglutide or Tirzepatide), which requires documented adherence over six months with time-stamped photo evidence. That guarantee does not extend to NAD+, Sermorelin, DNA testing, or any other service. Do not assume it covers your NAD+ subscription - it does not.

Damaged or incorrect medication: According to the company, replacements at no additional cost are available if medication arrives damaged (leaking, broken vials, or opened packaging) or if you receive the wrong item or incorrect dosage. You must contact the company within 7 days of delivery and provide clear photographs.

Review the complete refund policy, cancellation terms, and current subscription details on the official website before committing to any subscription.

Check current RNK Health NAD+ subscription terms (via partner page)

Safety Considerations: What Published Literature and Clinical Guidance Indicate

NAD+ therapy involves prescription-strength compounds. Published literature on NAD+ supplementation - primarily involving oral forms - has reported tolerability in research settings, though data on compounded injectable, nasal, or liposomal NAD+ remains limited and should be discussed with a licensed clinician. The following is a high-level overview, not a complete list of risks or precautions.

Commonly reported side effects in published research: Published literature on NAD+ supplementation reports injection site soreness, headache, nausea, muscle pain, fatigue, and sleep disturbances among the more frequently noted side effects. A systematic review examining NAD+ supplementation safety found that adverse events generally did not create serious health risks for study participants - though the review primarily evaluated oral supplementation rather than injectable or nasal delivery.

Injection-specific considerations: For injectable NAD+, the injection site may feel sore, burn, or appear red. Some people develop firm lumps where the fluid has not fully dispersed. Published sources describe these reactions as typically mild and temporary when proper injection technique is followed.

Potential medication interactions: Published research suggests that NAD+ may interact with several medication classes, including diabetes medications, blood pressure medications, anticoagulants, certain cancer treatments, and some antidepressants. Disclosing your full medication list to the evaluating clinician is not optional - it is essential.

Groups who should seek specific clearance: Based on published clinical guidance, individuals with diabetes or prediabetes, those taking blood thinners, anyone with active cancer or undergoing cancer treatment, pregnant or nursing individuals, and anyone with known liver conditions should discuss NAD+ therapy specifically with their clinician and obtain clearance before starting.

If your prescription documentation notes that any component is handled as a hazardous drug at the pharmacy level, follow the safe-handling and disposal instructions provided by your prescriber or pharmacist.

This safety overview is not exhaustive and does not replace the patient drug education or official prescribing information provided with your medication. Always review the full safety information that accompanies your prescription and consult your prescriber or pharmacist with any questions. NAD+ therapy is not a replacement for prescribed medical treatment for any health condition.

Questions You Should Ask a Licensed Clinician Before Choosing Any Telehealth NAD+ Program

Rather than suggesting who this program is or is not "right for" - which is a clinical determination, not an editorial one - it makes more sense to think about what questions you should bring to the table when you speak with the evaluating clinician.

What Is the Clinical Basis for Starting NAD+ Therapy?

NAD+ therapy is a subject of growing scientific interest, but the evidence base for injectable compounded NAD+ in humans is still developing. Ask the clinician what they are basing their recommendation on for your individual health profile and what outcomes they consider realistic.

Which NAD+ Delivery Format Is Appropriate - Injectable, Nasal, or Liposomal?

Each format involves a different administration method and potentially different absorption characteristics. The clinician - not the platform, not the marketing materials, and not this article - should be the one explaining which route they recommend and the reasoning behind it.

What Results Should You Realistically Expect From NAD+ Therapy, and Over What Timeframe?

RNK Health does not publish a specific results timeline for its NAD+ programs. The evaluating clinician should be able to discuss what changes, if any, you might notice and what factors could affect your individual response.

Can NAD+ Interact With Your Current Medications?

If you take any prescription medications - especially blood thinners, diabetes medications, blood pressure medications, or antidepressants - this conversation is non-negotiable. Do not skip it. Published research suggests NAD+ may interact with several medication classes, and your clinician needs your full medication list to evaluate safety.

What Happens if You Do Not Notice Any Benefit From RNK Health NAD+?

Given that the NAD+ refund policy does not provide refunds once medication has shipped, and that published research has produced mixed results across study populations, understanding the clinician's plan for adjusting or discontinuing therapy matters before you start - not after.

Does the RNK Health GLP-1 Money-Back Guarantee Apply to NAD+?

No. The company's "100% Money-Back Guarantee" applies exclusively to GLP-1 medications (Semaglutide and Tirzepatide) and requires documented adherence over six months with time-stamped evidence. It does not extend to NAD+, Sermorelin, DNA testing, or any other RNK Health service.

How Does RNK Health's NAD+ Billing and Cancellation Structure Work?

Monthly billing continues whether or not you have submitted your refill form. The cancellation window requires two-day advance notice before your billing date. Make sure the financial commitment fits the way you actually manage recurring expenses, not just the way you plan to.

Your answers to these questions - and the clinician's responses - should be the primary factors driving your decision, not marketing copy from any platform, including RNK Health.

RNK Health's Broader Platform: What Else the Company Offers

NAD+ is one piece of a broader telehealth platform. According to the company's website, RNK Health also lists weight management programs featuring compounded Semaglutide (from $197 per month) and compounded Tirzepatide (from $297 per month), a testosterone support program using Enclomiphene (from $189 per month), a muscle-focused program using Sermorelin (from $129 per month), and a DNA Blueprint service covering over 80 biomarkers ($399). All pricing is per the company's website and is subject to change.

Every program operates through the same three-entity telehealth structure described earlier in this article, with independent licensed clinicians making all prescribing decisions through the OpenLoop Healthcare Partners network.

Insurance, HSA, and FSA Considerations

Many direct-to-consumer prescription products, including compounded NAD+ therapy, are not covered by traditional insurance plans, but coverage policies vary by carrier and plan. Always confirm benefits directly with your insurer before assuming anything in either direction.

Some HSA (Health Savings Account) and FSA (Flexible Spending Account) plans may reimburse qualifying prescription expenses. Whether compounded NAD+ qualifies under your specific plan depends on your plan administrator's criteria. Check your specific plan rules before assuming eligibility.

Realistic Expectations: Where the Evidence Stands Today

Honest expectation-setting is more valuable than hype, so here is where things actually stand based on published research - not based on any platform's marketing language.

What the ingredient-level research supports: NAD+ supplementation has been shown in published studies to raise blood NAD+ levels in humans. Animal research and some human studies suggest potential effects in areas related to energy metabolism, cellular repair processes, and stress resilience. Some participants in research settings have reported subjective improvements in energy and focus - though individual responses vary significantly, and not all studies have shown measurable benefits.

What the research does not support: There is no published evidence establishing that compounded injectable, nasal, or liposomal NAD+ products from any telehealth platform produce specific guaranteed clinical outcomes. NAD+ therapy does not cure, treat, or reverse aging, disease, or any diagnosed health condition. It does not replace prescribed medical treatments. Results from animal studies do not automatically translate to identical outcomes in humans.

RNK Health does not publish a specific timeline for expected results from its NAD+ programs. Based on general published literature on NAD+-based regimens, some people report subjective changes within weeks while others report minimal or no noticeable difference. Individual factors - including age, baseline health, genetics, concurrent medications, and consistency of use - all play significant roles in determining whether and how someone responds.

Individual results will vary. NAD+ therapy is not a replacement for prescribed medical treatment. Consult your clinician before beginning any new prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your clinician's guidance.

Review current RNK Health NAD+ program information (via partner page)

Final Assessment: What to Weigh Before Making a Decision

What the platform offers, based on its published materials: RNK Health lists compounded prescription NAD+ in three delivery formats through a telehealth model that separates the platform, clinical decision-making, and pharmacy dispensing. The starting price of $129 per month positions the program as an at-home telehealth option compared to clinic-based models, though structure, pricing, and experience vary widely across providers. The subscription structure bundles clinical consultations, medication, and ongoing support within a single monthly price.

What to weigh carefully before committing: The NAD+ refund policy is restrictive - no refunds once medication ships, and dosage dissatisfaction is not grounds for a refund. The subscription auto-renews and requires advance notice to cancel before your billing date. The product pages on the website provide limited detailed clinical information, which means you are relying heavily on the clinician consultation to fill important gaps. The telehealth consent acknowledges that providers may include nurse practitioners or physician assistants, not exclusively physicians. And while the ingredient-level research on NAD+ is active and growing, the human clinical evidence base for compounded injectable NAD+ specifically remains limited compared to oral precursor studies.

Important note: The telehealth and compounded medication space has been under increased regulatory attention in recent years. The FDA has issued communications addressing risks associated with some compounded products, and the broader industry landscape continues to evolve. Consumers should review the most current information about any platform's regulatory standing and quality practices before proceeding with treatment.

Review current RNK Health NAD+ program details (via partner page)

Contact Information

For questions before or during the enrollment process, according to the company's website, RNK Health lists the following support channels:

Email: [email protected]
Phone/Text: +1 (551) 275-0869
Pharmacy Phone: (801) 839-5080
Pharmacy Address: 863 W 450 S, Ste 101, Springville, UT 84663
Medical Provider Address: 317 Sixth Avenue, Des Moines, Iowa 50309

According to the company's subscription FAQ, a 24/7 patient support line is described as included with the subscription service.

View current RNK Health NAD+ program information (via partner page)

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are based on published ingredient-level research and are not guarantees of outcomes from any specific compounded product. NAD+ therapy through RNK Health involves compounded prescription medications that require evaluation by a licensed clinician. The information provided here does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. NAD+ therapy is not a substitute for prescribed medical treatment. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your clinician before starting NAD+ therapy or any new prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your clinician's guidance and approval.

Compounded Medication Notice: RNK Health's NAD+ products are compounded prescription medications prepared by a licensed pharmacy based on individual prescriptions. Compounded medications are not reviewed or approved by the FDA as finished products. They are prepared using active ingredients sourced from FDA-registered facilities under the direction of a prescribing clinician. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.

Results May Vary: Individual results will vary based on factors including age, baseline health condition, lifestyle factors, consistency of use, genetic factors, current medications, delivery method selected, and other individual variables. Published research on NAD+ supplementation has produced mixed results across study populations. Not all individuals respond to NAD+ therapy, and results are not guaranteed.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on published research and publicly available information from the company's website.

Pricing Disclaimer: All prices, subscription terms, promotional offers, and program details mentioned were based on publicly available information from the RNK Health website at the time of publication (March 2026) and are subject to change without notice. Always verify current pricing, delivery options, and terms on the official RNK Health website before making your purchase.

Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication based on publicly available materials. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with RNK Health and their healthcare provider before making decisions.

Insurance Coverage Note: Many direct-to-consumer prescription products are not covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer. Some HSA/FSA plans may reimburse qualifying expenses; check your specific plan rules.

SOURCE: RNK Health

Source: RNK Health